Navigation Links
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Date:1/19/2009

MONT-SAINT-GUIBERT, Belgium, January 19 /PRNewswire/ --

- New Funds to Drive Clinical Development of C-Cure(R), a Second-Generation Cell-Based Therapy for Heart Failure

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, has raised EUR7.2 million in a successful Series B fund raising round. The new funds, which have come from a range of new and existing investors, will be used to finance the clinical development of the Company's lead product. C-Cure is a unique therapy that allows the differentiation of a patient's own cells into 'cardiopoietic' cells which grow into new heart cells and repair heart muscle. C-Cure holds the promise for a treatment that could fundamentally change the future of heart failure patients, one of the world's largest medical needs. The Company plans to enrol shortly approximately 240 patients in a clinical trial with C-Cure to evaluate its potential in the treatment of heart failure.

Cardio3 BioSciences was founded in 2007 by clinicians from the Cardiovascular Center in Aalst, Belgium with a vision of using a cell-based approach for the treatment of heart disease. The Company is led by a senior management team with extensive experience in developing and commercialising pharmaceutical and medical technologies and leverages proprietary technology developed by researchers from Mayo Clinic, a shareholder in the company. Following the successful B series fund raising, Cardio3 BioSciences has added new investors including the Belgium-based investment group Life Science Research Partners, a Luxemburg-based venture capital firm, Hunza Ventures II that focuses on life sciences, IT and cleantech industries, and Grifols, a Spanish holding company specialising in the pharmaceutical hospital industry. Other new investors were not disclosed.

In parallel with this equity fund
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today ... 2015.  The net loss and the loss from operations ... million, respectively, compared to $10.7 million and $8.8 million ... 31, 2015, Alexza had consolidated cash, cash equivalents, marketable ... "We continue to focus on ways in which to ...
(Date:5/6/2015)... The Parenteral Drug Association (PDA) Board of ... Richard M. Johnson to continue as President ... pleased to have Richard Johnson continue as ... the Chair of the Board of Directors. "Under Richard,s ... has led a strong staff and dedicated volunteers, hosting ...
(Date:5/6/2015)... Del. , May 6, 2015  Rigrodsky & Long, P.A.: ... Aerie Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did ... 2015, inclusive? , Did you lose money in your investment ... your rights? Rigrodsky & Long, P.A. ... MacFall , announces that a complaint has been filed in the ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... SPRING, Md., Oct. 21 The U.S. Food ... information has been added to the label for ... life-threatening side effects on the heart when used ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: ...
... ROCHESTER, N.Y., Oct. 21 VirtualScopics, Inc. (Nasdaq: ... for clinical trials, announced today that before the market ... its third quarter 2010 financial results. The company will ... EST. VirtualScopics, President and Chief Executive ...
Cached Medicine Technology:New Label Changes for Commonly Prescribed HIV Drug Invirase 2VirtualScopics Schedules Third Quarter 2010 Earnings Announcement 2
(Date:5/7/2015)... 2015 Learning ZoneXpress is supporting the ... in honor of National Physical Fitness and Sports Month. ... get the recommended physical activity guidelines for children and ... that adults:, , Aim for 2 ... week. Moderate activity includes things like walking fast, dancing, ...
(Date:5/7/2015)... 2015 Centurion Service Group , ... to announce the upcoming live auction to sell over ... and other medical facilities from around the United States. ... surgery, endoscopy, lab, anesthesia, infusion, exam and much more. ... 12 starting at 9:00am PDT. The equipment will be ...
(Date:5/7/2015)... More than most public figures, elite athletes capture the ... issues become public affairs and can damage or ruin careers. ... expert Katharine Nohr discusses how to approach risk ... Michael Phelps. , With a background in insurance defense litigation, ... company, Nohr Sports Risk Management. She is the author of ...
(Date:5/7/2015)... When people think about protecting their homes from ... than their basements. However, heavy rain falls also mean there ... While flooding is an obvious problem in a finished space; ... dry to avoid a musty smell . , ... amounts of water can cause foundation damage, mold growth, musty ...
(Date:5/7/2015)... Aureus Medical Group (aureusmedical.com), a leading medical ... and a variety of healthcare careers in most all ... top theme parks located across the continental ... healthcare professionals who are considering locations that are appealing ... opportunity for the travel nurse and other healthcare professionals ...
Breaking Medicine News(10 mins):Health News:Learning ZoneXpress announces new educational resource to celebrate National Physical Fitness and Sports Month 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 2Health News:Katharine Nohr Discusses Risk Management in Sports on SCI TV 3Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Get to Know the Top Theme Parks: Aureus Medical Releases Infographic for the Travel Nurse and Other Travel Healthcare Professionals 2
... , , JACKSONVILLE, Fla., Sept. ... makers of ACUVUE(R) Brand Contact Lenses is offering movie fans a chance ... this October, for themselves and 50 friends. The grand prize also ... of ACUVUE(R) Brand Contact Lenses. , , Fans can ...
... Health Access Program Awards Minnesota Up to $35 Million Over Five ... , ST. PAUL, Minn., Sept. 22 Portico Healthnet, ... coverage for health care services, has been named as a partner ... announced effort to expand health care access to uninsured Minnesotans. The ...
... , MOUNTAIN VIEW, Calif., Sept. 22 ... publication of results from an in vitro study of ... the potential mechanism by which the pharmacokinetics (PK) and pharmacodynamics of ... dihydroergotamine (DHE). Results will be published in a manuscript titled ...
... , , , ... show hosted by cardiac surgeon and health expert Dr. Mehmet Oz, and the ... the Reliant Convention Center in Houston, Texas on Saturday September 26, 2009 to ... health insurance. Dr. Oz will participate in the event and will devote ...
... Departing Chicago via Vespa Scooter, Schaller to Ride Through Seven Western States ... Md., Sept. 22 Emily Schaller, a 27-year-old drummer with cystic fibrosis ... from Chicago to Burbank, California, in her quest to get on "The ... is to raise awareness about cystic fibrosis, has appeared in ...
... found that hormone therapy used to treat men with advanced ... various heart problems. Some choices of therapy appear, however, to ... biggest cancer congress, ECCO 15 ESMO 34 [1], in ... study, the largest and most comprehensive to date on the ...
Cached Medicine News:Health News:ACUVUE(R) Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 2Health News:ACUVUE(R) Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 3Health News:Portico Healthnet Named Partner in Increasing Health Care Access Via Federal Grant 2Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 2Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 3Health News:'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile 4Health News:'The Dr. Oz Show' and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houston's Reliant Convention Center on September 26 2Health News:'The Dr. Oz Show' and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houston's Reliant Convention Center on September 26 3Health News:'The Dr. Oz Show' and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houston's Reliant Convention Center on September 26 4Health News:'The Dr. Oz Show' and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houston's Reliant Convention Center on September 26 5Health News:Cystic Fibrosis Patient Emily Schaller Begins 2,000-Mile Quest to Get on 'The Ellen DeGeneres Show' 2Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 2Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 3Health News:Prostate cancer patients on hormone therapy at increased risk for various heart diseases 4
... unique label design & production suite ... and intuitive user interface designed specifically ... a family of professional labeling software ... and complete barcode printing solution for ...
... The WatchMate system is designed to ... facility undetected and becoming lost or injured. ... dementia, Alzheimer's etc., or have suffered a ... Watchlet™ bracelet on their wrist or ankle, ...
... Wi-Fi Tags are small, long-life Active RFID ... By attaching tags to mobile assets or ... to locate and track many different assets ... and revenues. The AeroScout T2 Tag can ...
... PDC Smart™ Labels have a ... a Texas Instruments Tag-it™ HF-I transponder. ... bar codes, text and other graphics ... time variable data is programmed to ...
Medicine Products: